{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:09:16Z","timestamp":1793372956158,"version":"4.5.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/13696998.2024.2444836","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T10:02:54Z","timestamp":1734688974000},"page":"186-195","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness of outpatient COVID-19 antiviral treatment with nirmatrelvir\/ritonavir versus usual care in Swedish patients with various risk factors"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1905-4047","authenticated-orcid":false,"given":"Fredrik","family":"Nilsson","sequence":"first","affiliation":[{"name":"Pfizer AB, Access and Value","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9854-6009","authenticated-orcid":false,"given":"Martina","family":"Aldv\u00e9n","sequence":"additional","affiliation":[{"name":"Pfizer AB, Access and Value","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7772-5451","authenticated-orcid":false,"given":"Christian","family":"Gerdesk\u00f6ld Rappe","sequence":"additional","affiliation":[{"name":"Pfizer AB, Medical Affairs","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-8548","authenticated-orcid":false,"given":"Tendai","family":"Mugwagwa","sequence":"additional","affiliation":[{"name":"Global Access and Value","place":["Tadworth, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.econmod.2023.106551"},{"key":"e_1_3_4_3_1","unstructured":"World Health Organization. COVID-19 epidemiological update \u2013 17 May 2024: World Health Organization; 2024 [cited 2024 May 30]. Available from: https:\/\/www.who.int\/publications\/m."},{"key":"e_1_3_4_4_1","unstructured":"KFF. Global COVID-19 Tracker; 2024 [cited 2024 October 4]. Available from: https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/global-covid-19-tracker\/."},{"key":"e_1_3_4_5_1","unstructured":"World Health Organization. WHO COVID-19 dashboard: World Health Organization; 2024 [cited 2024 October 4]. Available from: https:\/\/data.who.int\/dashboards\/covid19\/deaths?n=c."},{"key":"e_1_3_4_6_1","unstructured":"Statista. Number of COVID-19 vaccine doses administered in Europe as of January 18; 2023 by country 2023 [cited 2024 June 6]. Available from: https:\/\/www.statista.com\/statistics\/1196071\/covid-19-vaccination-rate-in-europe-by-country\/."},{"key":"e_1_3_4_7_1","unstructured":"Socialstyrelsen. Statistics on COVID-19: socialstyrelsen; 2022 [cited 2024 May 28]. Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/alla-statistikamnen\/lagesbild-covid-19-influensa-och-rs-statistik\/statistik-om-doda-covid-19-influensa-och-rs-virus\/."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00118-4"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00011-7"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/M22-2141"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284006"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309003"},{"key":"e_1_3_4_14_1","unstructured":"Nationellt v\u00e5rdprogram f\u00f6r misst\u00e4nkt och bekr\u00e4ftad covid 19. (National Treatment Guidelines Covid 19) https:\/\/infektion.net\/wpcontent\/uploads\/2023\/06\/nationellt_vardprogram_covid19_ver5_revision5_1.pdf"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06378-z"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00732-w"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.01.118"},{"key":"e_1_3_4_18_1","unstructured":"Wahlstr\u00f6m E Str\u00e5lin K Holm J et\u00a0al. Who was at increased risk of severe covid-19 during the first omicron wave?: Lakartidningen; 2023 [cited 2024 June 6]. Available from: https:\/\/lakartidningen.se\/opinion\/debatt\/2023\/05\/vilka-hade-forhojd-risk-for-svar-covid-19-under-forsta-omikronvagen\/."},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.11.003"},{"key":"e_1_3_4_20_1","unstructured":"Socialstyrelsen. \u00d6vergripande statistik covid-19; 2024 [cited 2024 August 21]. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/statistik\/statistik-covid19-overgripande.xlsx."},{"key":"e_1_3_4_21_1","unstructured":"Socialstyrelsen. \u00d6vergripande statistik \u00f6ver slutenv\u00e5rdade med covid-19; 2024 [cited 2024 September 2]. Available from: https:\/\/www.socialstyrelsen.se\/statistik-och-data\/statistik\/statistik-om-covid-19\/."},{"key":"e_1_3_4_22_1","unstructured":"Socialstyrelsen. \u00d6vergripande statistik covid-19: Ej Intensivv\u00e5rdade; 2024 [cited 2024 September 2]. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/statistik\/statistik-covid19-overgripande.xlsx."},{"key":"e_1_3_4_23_1","unstructured":"Socialstyrelsen. \u00d6vergripande statistik covid-19: intensivv\u00e5rdade; 2024 [cited 2024 September 2]. Available from: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/dokument-webb\/statistik\/statistik-covid19-overgripande.xlsx."},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00327-0"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0743"},{"key":"e_1_3_4_26_1","unstructured":"Pfizer - data on file. EPIC HR clinical study report release 08 March 2023 (Section 6); 2023."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.10.029"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199711000-00002"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01168-0"},{"key":"e_1_3_4_30_1","unstructured":"Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverket (TLV). Pris- och beslutsdatabasen; 2024 [cited 2024 July 18]. Available from: https:\/\/www.tlv.se\/beslut\/sok-priser-och-beslut-i-databasen.html."},{"key":"e_1_3_4_31_1","unstructured":"S\u00f6dra sjukv\u00e5rdsregionen. Regionala priser och ers\u00e4ttningar f\u00f6r S\u00f6dra sjukv\u00e5rdsregionen; 2024. 2023. p. Infektionssjukdomar - Slutenv\u00e5rd - \u201cVARDDAG\u201d - Omv\u00e5rdnadsdag."},{"key":"e_1_3_4_32_1","unstructured":"S\u00f6dra sjukv\u00e5rdsregionen. Regionala priser och ers\u00e4ttningar f\u00f6r S\u00f6dra sjukv\u00e5rdsregionen; 2023. 2022. p. Intensivv\u00e5rd - omv\u00e5rdnadsdag covid."},{"key":"e_1_3_4_33_1","unstructured":"Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverket (TLV). Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverkets allm\u00e4nna r\u00e5d: \u00c4ndring i Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverkets allm\u00e4nna r\u00e5d (TLVAR 2003:2) om ekonomiska utv\u00e4rderingar; 2017."},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.09.1686"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2444836","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:47:13Z","timestamp":1766400433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2444836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2444836"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2444836","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}